EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Concordance Rate Between Examination of EGFR Mutation Blood Plasma Sample (ctDNA) With Citological/Histopathological Sample in Adenocarcinoma Lung Cancer

Dian Utami Wulaningrum, Ana Rima Setijadi, Suradi Suradi

Respiratory Science · 2020

DOI: 10.36497/respirsci.v1i1.9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiratory Science, 2020. Verfasst von Dian Utami Wulaningrum und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Most adenocarcinoma lung cancer which is found at an advanced stage with cytology / histopathological samples is hardly available. Examination of EGFR mutations in ctDNA blood plasma sampling is simpler and easier, which also can be used as predictive and prognostic markers in non-small cell carcinoma lung cancer patients. The purpose of this study is to determine and analyse the degree of compatibility between examination of EGFR mutations by blood plasma (ctDNA) samples with the examination of cytology / histopathological EGFR mutations in adenocarcinoma lung cancer.

Methods

Diagnostic test research, by taking medical records of patients with adenocarcinoma lung cancer from January to September 2019 at Dr. Moewardi Surakarta, who was examined by EGFR mutations in cytology / histopathology and ctDNA samples.

Result

The Subjects of this study were 73 patients with adenocarcinoma lung cancer. The level of compatibility of ctDNA with EGFR mutations in cytology / histopathology samples was categorized as moderate and statistically significant (Kappa = 0.459; p = 0.000).

Conclusion

The level of concordance between the examination of EGFR mutations with blood plasma samples (ctDNA) with the examination of EGFR mutations in cytology / histopathology samples was moderate and statistically significant.

Zitieren

APA

Wulaningrum, D. U., Setijadi, A. R., & Suradi, S. (2020). Concordance Rate Between Examination of EGFR Mutation Blood Plasma Sample (ctDNA) With Citological/Histopathological Sample in Adenocarcinoma Lung Cancer. Respiratory Science. https://doi.org/10.36497/respirsci.v1i1.9

Vancouver

Wulaningrum DU, Setijadi AR, Suradi S. Concordance Rate Between Examination of EGFR Mutation Blood Plasma Sample (ctDNA) With Citological/Histopathological Sample in Adenocarcinoma Lung Cancer. Respiratory Science. 2020. doi:10.36497/respirsci.v1i1.9

BibTeX
@article{Wulaningrum2020,
  author = {Wulaningrum, Dian Utami and Setijadi, Ana Rima and Suradi, Suradi},
  title = {Concordance Rate Between Examination of EGFR Mutation Blood Plasma Sample (ctDNA) With Citological/Histopathological Sample in Adenocarcinoma Lung Cancer},
  journal = {Respiratory Science},
  year = {2020},
  doi = {10.36497/respirsci.v1i1.9}
}
Kostenlos starten →